{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:23:34Z","timestamp":1791429814871,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.anndiagpath.2025.152504","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:17:55Z","timestamp":1747768675000},"page":"152504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Granuloma rich hepatocellular carcinoma (GrHCC): Clinicopathologic and genomic characterization"],"prefix":"10.1016","volume":"79","author":[{"given":"Mukul","family":"Vij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexmi Priya","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Jothimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subathra","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Ann","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowripriya","family":"Gowrishankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komalavalli","family":"Subbiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Rajalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilankumaran","family":"Kaliamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Rammohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2025.152504_bb0005","article-title":"Sarcoid-like reaction in patients with malignant tumors: long-term clinical course and outcomes","volume":"9","author":"Huh","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"13\u201314","key":"10.1016\/j.anndiagpath.2025.152504_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10354-014-0269-x","article-title":"Sarcoidosis vs. sarcoid-like reactions: the two sides of the same coin?","volume":"164","author":"Tchernev","year":"2014","journal-title":"Wien Med Wochenschr"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152504_bb0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2006.07365.x","article-title":"Unusualhistopathological features of cutaneous leishmaniasis identified by polymerase chain reaction specific for Leishmania on paraffin-embedded skin biopsies","volume":"155","author":"B\u00f6er","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejca.2020.02.024","article-title":"Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: increased rate and mimicker of metastasis","volume":"131","author":"Chorti","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.anndiagpath.2017.07.003","article-title":"Sarcoid-like granulomas in renal cell carcinoma: the Houston Methodist Hospital experience","volume":"31","author":"Arora","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152504_bb0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/his.14633","article-title":"Granulomas associated with renal neoplasms: a multi-institutionalclinicopathological study of 111 cases","volume":"80","author":"Sangoi","year":"2022","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152504_bb0035","article-title":"Sarcoid-like reactions in breast cancer patients: a report of two cases","volume":"16","author":"Marinos","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152504_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0305-7372(86)90002-2","article-title":"Sarcoid reactions in malignant tumours","volume":"13","author":"Brincker","year":"1986","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152504_bb0045","first-page":"133","article-title":"Hepatocellular carcinomas with granulomatous inflammation in tumor stroma: clinicopathologic characteristics","volume":"38","author":"Saka","year":"2022","journal-title":"Turk Patoloji Derg"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152504_bb0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.humpath.2011.05.006","article-title":"Sarcoidal reactions in regional lymph nodes of patients with early stage non-small celllung cancer predict improved disease-free survival: a pilot case-control study","volume":"43","author":"Steinfort","year":"2012","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152504_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4254\/wjh.v13.i4.393","article-title":"Pathologic and molecular features of hepatocellular carcinoma: an update","volume":"13","author":"Vij","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0060","series-title":"WHO classification of tumors editorial board. Digestive system tumours. WHO classification of tumours series","first-page":"229","article-title":"Hepatocellular carcinoma","author":"Torbenson","year":"2019"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152504_bb0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer","volume":"71","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152172","article-title":"Frequent expression of PD-L1 in lymphocyte- rich hepatocellular carcinoma: a report of 4 cases","volume":"66","author":"Vij","year":"2023","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0075","article-title":"Clinicopathological characteristics of neutrophil-rich hepatocellular carcinoma: an uncommon subtype of primary liver cancer","author":"Vij","year":"2024","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152504_bb0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.humpath.2005.02.017","article-title":"Inflammatory cells in the formation of tumor-related sarcoid reactions","volume":"36","author":"Kurata","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0085","article-title":"Sarcoid-like reaction in a patient with colon cancer: a case report and mini-review","author":"Ikeshita","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0090","first-page":"538","article-title":"Epithelioid granulomas associated with hepatocellular carcinoma","volume":"106","author":"Tomimatsu","year":"1982","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/dc.1087","article-title":"Fine-needle aspiration of hepatocellular carcinoma: false-negative result due to epithelioid cells","volume":"24","author":"Mourra","year":"2001","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2559.2002.t01-3-01294.x","article-title":"Granulomas in hepatocellular carcinoma induced by lipiodolized SMANCS, a polymer-conjugated derivative of neocarzinostatin","volume":"40","author":"Ichikawa","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40792-021-01146-2","article-title":"Hepatocellular carcinoma with regional lymphadenopathy caused by sarcoid-like reaction: a case report","volume":"7","author":"Mizota","year":"2021","journal-title":"Surg Case Rep"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152504_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.prp.2011.03.003","article-title":"Hepatic granulomas: a clinicopathologic analysis of 86 cases","volume":"207","author":"Turhan","year":"2011","journal-title":"Pathol Res Pract"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152504_bb0115","first-page":"493","article-title":"Global epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"4","author":"Younossi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152504_bb0120","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00061-2020","article-title":"Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study","volume":"6","author":"Murthi","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0125","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/JHC.S342266","article-title":"Recurrent hepatocellular carcinoma: patterns, detection, staging and treatment","volume":"9","author":"Papaconstantinou","year":"2022","journal-title":"J Hepatocell Carcinoma"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152504_bb0130","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1245\/s10434-020-08452-3","article-title":"Recurrence patterns and outcomes after resection of hepatocellular carcinoma within and beyond the Barcelona clinic liver cancer criteria","volume":"27","author":"Tsilimigras","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2024.152382","article-title":"Clinicopathologic features and tumor immune microenvironment of lymphocyte-rich hepatocellular carcinoma","volume":"73","author":"Zhang","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev-immunol-032712-100022","article-title":"The formation and function of granulomas","volume":"36","author":"Pag\u00e1n","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"5b","key":"10.1016\/j.anndiagpath.2025.152504_bb0145","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1111\/bju.12334","article-title":"Prognostic value ofinflammation or granuloma after intravesival BCG in non-muscle-invasive bladder cancer","volume":"113","author":"Jallad","year":"2014","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152504_bb0150","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1478-3231.2008.01695.x","article-title":"Hepatic granulomas: histological and molecular pathological approach to differential diagnosis\u2014a study of 442 cases","volume":"28","author":"Drebber","year":"2008","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152504_bb0155","first-page":"69","article-title":"Liver involvement in tuberculosis\u2014an autopsy study","volume":"27","author":"Amarapurkar","year":"2006","journal-title":"Trop Gastroenterol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2025.152504_bb0160","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/00000478-199312000-00009","article-title":"Hepaticsarcoidosis. Clinicopathologic features in 100 patients","volume":"17","author":"Devaney","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152504_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70037","article-title":"Insights into hepatic sarcoidosis: analysis of histological patterns, hepatic complications and therapeutic approaches","volume":"45","author":"Horst","year":"2025","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152504_bb0170","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cld.2010.07.005","article-title":"Hepatic granulomas: pathogenesis and differential diagnosis","volume":"14","author":"Lagana","year":"2010","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152504_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000392","article-title":"Granulomatous liver diseases","volume":"8","author":"Mironova","year":"2024","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152504_bb0180","doi-asserted-by":"crossref","first-page":"867","DOI":"10.5858\/arpa.2014-0123-RA","article-title":"Hepatic granulomas: a review with emphasis on infectious causes","volume":"139","author":"Lamps","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"3\u20134","key":"10.1016\/j.anndiagpath.2025.152504_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/j.semdp.2006.11.003","article-title":"Granulomas in the liver","volume":"23","author":"Kleiner","year":"2006","journal-title":"Semin Diagn Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2025.152504_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101799","article-title":"Clinicopathological assessment of steatohepatitic hepatocellular carcinoma","volume":"46","author":"Yamaoka","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152504_bb0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-21-1258","article-title":"NASH and hepatocellular carcinoma: immunology and immunotherapy","volume":"29","author":"Pinter","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.870458","article-title":"Tertiary lymphatic structures in primary hepatic carcinoma: controversy cannot overshadow hope","volume":"13","author":"Jia","year":"2022","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.anndiagpath.2025.152504_bb0205","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","article-title":"Glycogen accumulation and phase separation drives liver tumor initiation","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.anndiagpath.2025.152504_bb0210","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jtho.2018.04.031","article-title":"Sarcoidosis-like reactions induced by checkpoint inhibitors","volume":"13","author":"Gkiozos","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152504_bb0215","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152504_bb0220","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2016.05.035","article-title":"Genetic profiling of hepatocellular carcinoma using next-generation sequencing","volume":"65","author":"Schulze","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0225","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse- transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"Nault","year":"2013","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152504_bb0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s13577-019-00295-9","article-title":"CCND1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy","volume":"33","author":"Zhang","year":"2020","journal-title":"Hum Cell"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152504_bb0235","first-page":"168","article-title":"Predicting responsiveness to sorafenib: can the determination of FGF3\/FGF4 amplifications enrich for clinical benefit?","volume":"3","author":"Harding","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152504_bb0240","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152504_bb0245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12920-021-00998-9","article-title":"Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinoma","volume":"14","author":"Peng","year":"2021","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152504_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40404-1","article-title":"Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K\/AKT pathwayand inducing macrophage M2 polarization","volume":"13","author":"Yue","year":"2023","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.anndiagpath.2025.152504_bb0255","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.3390\/ijms22126560","article-title":"The impact of the tumor microenvironment on macrophage polarization in cancer metastatic progression","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111537","article-title":"Apolipoprotein C3 (ApoC3) facilitates NLRP3 mediated pyroptosis of macrophages through mitochondrial damage by accelerating of the interaction between SCIMP and SYK pathway in acute lung injury","volume":"128","author":"Pu","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152504_bb0265","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2014.01.018","article-title":"RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance","volume":"19","author":"Moraes-Vieira","year":"2014","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152504_bb0270","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.anndiagpath.2025.152504_bb0275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fimmu.2014.00330","article-title":"Toll-like receptor 9 in breast cancer","volume":"5","author":"Sandholm","year":"2014","journal-title":"Front Immunol"},{"issue":"1\u20133","key":"10.1016\/j.anndiagpath.2025.152504_bb0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0960-0760(92)90184-K","article-title":"Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications","volume":"43","author":"Reubi","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"16","key":"10.1016\/j.anndiagpath.2025.152504_bb0285","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/onc.2016.377","article-title":"ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma","volume":"36","author":"Hazawa","year":"2017","journal-title":"Oncogene"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T01:11:28Z","timestamp":1755825088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913425000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S1092913425000693"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152504","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granuloma rich hepatocellular carcinoma (GrHCC): Clinicopathologic and genomic characterization","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152504"}}